Deep Tech Startups

Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage. The company serves healthcare providers with medical technology aimed at earlier sepsis diagnosis.

1 investor

Valcare Medical develops transcatheter solutions for treating mitral regurgitation, a structural heart condition, aiming to provide surgical-level durability without open-heart surgery. The company's flagship system is designed for interventional cardiologists and patients requiring mitral valve repair.

1 investor

Valen designs drugs using computational biology and experimental data generation. The company serves pharmaceutical and biotech researchers developing the next generation of therapeutics.

1 investor

Valence builds an emotional communication layer for AI systems, aiming to give them functional emotional understanding by modeling not just intent but impact. The company focuses on AI alignment through emotionally intelligent, transparent, and human-guided technology.

1 investor

Valence Labs is an AI research engine that develops computational models to predict cellular responses to genetic and chemical interventions for drug discovery. The company focuses on building virtual cells to accelerate the identification of effective therapeutics.

1 investor

Valgotech designs lithium-sulfur battery cells for defense and aerospace platforms, focusing on energy density, thermal safety, and supply chain independence from conflict minerals. The company serves defense primes, UAV manufacturers, and aerospace integrators.

1 investor

ValleyDAO provides funding and community support to research scientists and entrepreneurs developing unconventional biotech projects, offering grants up to $250k with rapid turnaround and access to a network of investors and thought leaders.

1 investor

Valory builds Olas, an open-source stack and decentralized marketplace for autonomous AI agents, including a desktop "agent app store" that lets users own and run AI agents for use cases from social influencers to DeFAI. The platform enables agents to offer or hire services from one another and earn crypto.

1 investor

Valys provides water management technology and monitoring solutions that help customers optimize water production processes and reduce operational costs while supporting environmental protection.

1 investor

A biomanufacturing company with deep expertise in bioprocessing, process development, and chemically-defined media systems, led by a team of scientists with extensive experience in cell therapy and biologics manufacturing.

1 investor

Vandeyk.racing designs and manufactures high-performance cycling apparel focused on minimalist design principles. The company also operates vandeyk.tech, a deep-tech B2B division developing advanced textile technologies for the global textile industry in partnership with the Fraunhofer Society.

1 investor

Vanellus provides GPU-native, finite-volume CFD and thermal simulation software for electronics cooling design, delivered through a browser-accessible workflow with cloud GPU solvers and automated meshing. It serves thermal engineers, product designers, and team leads working on dense electronics such as server blades, consumer electronics, and data centers.

1 investor

Vantari provides VR-based procedural training for healthcare professionals, combining immersive simulation with AI-powered performance analytics and a community platform for medical education.

1 investor

Vantor provides professional services including training programs, custom analytics, and consulting to help organizations build spatial intelligence systems and develop workforce expertise.

1 investor

VARIANT3D develops LOOP, a software platform that enables designers and brands to create custom knitted textiles digitally and produce them at scale. The company bridges digital design with physical manufacturing for the apparel and textile industry.

1 investor

Variant provides compiler-level software protection that makes each build of a program structurally unique while keeping it functionally identical, so an exploit extracted from one device cannot be reused across an entire fleet. It targets AI-driven exploitation of embedded or fleet-deployed software.

1 investor

VascuBio Innovation develops microfluidics, biomaterials, and biofabrication platforms—including bioreactors, screening systems, and organ-on-chip technologies—for drug screening, tissue engineering, and regenerative medicine. Founded on academic research connected to McGill University, it serves researchers and industry seeking human-relevant in vitro models that reduce reliance on animal testing.

1 investor

VascVersa develops a platform for vascular stem cell therapy and cell therapy manufacturing, serving the advanced therapies and clinical development sectors in vascular biology.

1 investor

ZOZO NEXT is a Japanese company within the ZOZO Group focused on creating new fashion-related businesses and conducting R&D, centered on the ZOZO Research Institute, to solve user problems in fashion through technology.

1 investor

Vast.ai provides on-demand access to GPUs and specialized compute hardware for running AI models and intensive computing workloads. The platform serves developers and organizations seeking lower-cost alternatives to major cloud providers with pay-per-second pricing and support for multiple GPU architectures.

1 investor

CAV Solutions provides age and ID verification technology to prevent age-restricted sales to minors at the point of transaction. The company serves retailers and merchants who need to automate identity verification processes.

1 investor

VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.

1 investor

Vcreate uses machine learning and single-cell sequencing screening assays to engineer human T-cell receptors (TCRs) for TCR-based therapies that target disease-specific antigens, including rare cancer mutations. Its platform screens hundreds of millions of TCR-antigen interactions to design receptors that activate against targets inside cells that are otherwise difficult to drug.

1 investor

VDI/VDE Innovation + Technik GmbH is a German organization that manages and supports innovation and technology funding programs, focused on promoting future technologies, competitiveness, and resilience for Germany as a business location.

1 investor